ATE326536T1 - Herstellung von biologisch aktiven molekülen - Google Patents

Herstellung von biologisch aktiven molekülen

Info

Publication number
ATE326536T1
ATE326536T1 AT00919108T AT00919108T ATE326536T1 AT E326536 T1 ATE326536 T1 AT E326536T1 AT 00919108 T AT00919108 T AT 00919108T AT 00919108 T AT00919108 T AT 00919108T AT E326536 T1 ATE326536 T1 AT E326536T1
Authority
AT
Austria
Prior art keywords
production
biologically active
active molecules
molecules
biologically
Prior art date
Application number
AT00919108T
Other languages
English (en)
Inventor
Menachem Rubinstein
Bianling Liu
Daniela Novick
Pierre Graber
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE326536T1 publication Critical patent/ATE326536T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
AT00919108T 1999-04-13 2000-04-13 Herstellung von biologisch aktiven molekülen ATE326536T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL12942799A IL129427A0 (en) 1999-04-13 1999-04-13 Preparation of biologically active molecules

Publications (1)

Publication Number Publication Date
ATE326536T1 true ATE326536T1 (de) 2006-06-15

Family

ID=11072700

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00919108T ATE326536T1 (de) 1999-04-13 2000-04-13 Herstellung von biologisch aktiven molekülen

Country Status (24)

Country Link
US (1) US7098002B1 (de)
EP (1) EP1169460B1 (de)
JP (1) JP4822587B2 (de)
KR (1) KR100682185B1 (de)
CN (1) CN1324140C (de)
AR (1) AR023468A1 (de)
AT (1) ATE326536T1 (de)
AU (1) AU781342B2 (de)
BR (1) BR0009782A (de)
CA (1) CA2368994C (de)
DE (1) DE60028022T2 (de)
DK (1) DK1169460T3 (de)
EA (1) EA006825B1 (de)
EE (1) EE05591B1 (de)
ES (1) ES2259287T3 (de)
HK (1) HK1044351A1 (de)
IL (3) IL129427A0 (de)
MX (1) MXPA01010487A (de)
NO (1) NO329525B1 (de)
PT (1) PT1169460E (de)
SI (1) SI1169460T1 (de)
UA (1) UA73940C2 (de)
WO (1) WO2000061768A2 (de)
ZA (1) ZA200108364B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001029232A2 (en) * 1999-10-20 2001-04-26 Scios Inc. Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage
US7273722B2 (en) 2000-11-29 2007-09-25 Allergan, Inc. Neurotoxins with enhanced target specificity
BRPI0207933B8 (pt) 2001-03-08 2021-05-25 Ares Trading Sa polipeptídeo mutante de interleucina-18 e composição farmacêutica
IL142246A0 (en) * 2001-03-26 2002-03-10 Applied Research Systems Method and kit for quantitation of polypeptides
EP1483298A4 (de) 2002-02-11 2007-03-14 Zymogenetics Inc Materialien und verfahren zur herstellung dimerer wachstumsfaktoren
AU2004213586B2 (en) * 2003-02-21 2009-01-15 Biotecnol S.A. Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions
EP1651751B1 (de) * 2003-08-06 2015-11-18 University Of Maryland Biotechnology Institute Gentechnisch hergestellte proteasen zur affinitätsreinigung und prozessierung von fusionsproteinen
EP1689877A1 (de) * 2003-11-24 2006-08-16 Novo Nordisk A/S Fusionsproteine und verfahren zur spaltung solcher proteine
CA2558811A1 (en) 2004-03-08 2005-09-22 Zymogenetics, Inc. Dimeric fusion proteins and materials and methods for producing them
ATE463506T1 (de) * 2005-09-19 2010-04-15 Allergan Inc Mit clostriedientoxin aktivierbare clostridientoxine
WO2007122975A1 (ja) * 2006-04-20 2007-11-01 Kringle Pharma Inc. Ｈｇｆ前駆体蛋白質改変体及びその活性型蛋白質
DE102007008596B4 (de) * 2007-02-15 2010-09-02 Friedrich-Schiller-Universität Jena Biologisch wirksame Moleküle auf Grundlage von PNA und siRNA, Verfahren zu deren zellspezifischen Aktivierung sowie Applikationskit zur Verabreichung
WO2009025846A2 (en) 2007-08-22 2009-02-26 The Regents Of The University Of California Activatable binding polypeptides and methods of identification and use thereof
WO2009044988A1 (en) * 2007-10-01 2009-04-09 Korea Research Institute Of Bioscience And Biotechnology Method for large scale preparation of procaspases, which can be artificially activated, in e. coli expression system and their activation
DE102009043743B4 (de) 2009-03-13 2016-10-13 Friedrich-Schiller-Universität Jena Zellspezifisch wirksame Moleküle auf Grundlage von siRNA sowie Applikationskits zu deren Herstellung und Verwendung
CN106995495A (zh) 2009-01-12 2017-08-01 希托马克斯医疗有限责任公司 修饰抗体组合物及其制备和使用方法
US8399219B2 (en) 2009-02-23 2013-03-19 Cytomx Therapeutics, Inc. Protease activatable interferon alpha proprotein
CN103923897B (zh) * 2013-01-11 2016-06-01 中国人民解放军军事医学科学院生物工程研究所 caspase重组酶原及其编码基因与应用
CN103388001B (zh) * 2013-07-16 2016-01-20 中国人民解放军第四军医大学 一种含凝血酶切割位点gst膜型表达载体及转染阳性细胞的方法
US10370692B2 (en) 2013-12-20 2019-08-06 Hoffmann-La Roche Inc. Recombinant polypeptide production methods
CR20170485A (es) 2015-03-30 2018-02-05 Greenlight Biosciences Inc Producción de ácido ribonucleico libre de células
PE20221008A1 (es) 2015-06-24 2022-06-15 Hoffmann La Roche Anticuerpos anti-receptor de transferrina con afinidad disenada
AR106189A1 (es) 2015-10-02 2017-12-20 Hoffmann La Roche ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
PE20181004A1 (es) 2015-10-02 2018-06-26 Hoffmann La Roche Anticuerpos biespecificos contra el cd20 humano y el receptor de transferrina humano y metodos de uso
JP7011599B2 (ja) 2016-04-06 2022-02-10 グリーンライト バイオサイエンシーズ インコーポレーテッド リボ核酸の無細胞的生産
EP3695002A1 (de) 2017-10-11 2020-08-19 GreenLight Biosciences, Inc. Verfahren und zusammensetzungen zur herstellung von nukleosidtriphosphat und ribonukleinsäure
KR20200080749A (ko) * 2018-12-27 2020-07-07 주식회사 폴루스 N-말단의 메티오닌이 절단된 목적 단백질 발현용 유전자 발현 카세트 및 이를 이용하여 n-말단의 메티오닌이 절단된 목적 단백질을 생산하는 방법
CN114555791A (zh) * 2019-08-13 2022-05-27 伦敦国王学院 Il-1超家族时空限制性活性细胞因子铠装的免疫应答细胞

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824297A (en) * 1990-06-25 1998-10-20 Oncogene Science, Inc. Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
AU659412B2 (en) * 1990-06-25 1995-05-18 Osi Pharmaceuticals, Inc. Tissue-derived tumor growth inhibitors
DE69229252T2 (de) * 1991-08-16 1999-12-16 Merck & Co Inc DNS, welche das Interleukin-1B-Vorläufer-Converting-Enzym kodiert
DK0624199T3 (da) 1991-12-31 1999-11-01 Zymogenetics Inc Fremgangsmåder til fremstilling af thrombin
JPH06125784A (ja) * 1992-01-17 1994-05-10 Takeda Chem Ind Ltd モノクローナル抗体，ハイブリドーマ，その製造法および用途
US6303369B1 (en) * 1993-09-30 2001-10-16 Carl Spana Protein expression system
AU1341797A (en) 1995-12-29 1997-07-28 Incyte Pharmaceuticals, Inc. Nucleic acids encoding interferon gamma inducing factor-2
JP4059941B2 (ja) * 1996-08-26 2008-03-12 社団法人芝蘭会 Ｒｈｏ標的タンパク質ｐ１４０ｍＤｉａ
AT405516B (de) * 1997-02-27 1999-09-27 Immuno Ag Faktor x-analoge mit modifizierter proteasespaltstelle
JPH10327872A (ja) * 1997-05-30 1998-12-15 Otsuka Pharmaceut Co Ltd Ｂｃｌ−２相互作用蛋白遺伝子ｂｉｓ
CA2295957C (en) 1997-08-07 2009-09-22 Toray Industries, Inc. Canine interleukin 18, canine interleukin 1.beta. converting enzyme, dna sequences encoding these, interleukin 18 production method and canine immune disease remedy

Also Published As

Publication number Publication date
NO20014966D0 (no) 2001-10-12
CN1353761A (zh) 2002-06-12
MXPA01010487A (es) 2002-05-06
EA006825B1 (ru) 2006-04-28
UA73940C2 (uk) 2005-10-17
ES2259287T3 (es) 2006-10-01
HK1044351A1 (en) 2002-10-18
JP2002541813A (ja) 2002-12-10
SI1169460T1 (sl) 2006-08-31
AU781342B2 (en) 2005-05-19
AR023468A1 (es) 2002-09-04
BR0009782A (pt) 2002-01-08
NO20014966L (no) 2001-12-11
IL145842A0 (en) 2002-07-25
EA200101078A1 (ru) 2002-04-25
AU3985100A (en) 2000-11-14
DE60028022T2 (de) 2006-09-28
JP4822587B2 (ja) 2011-11-24
PT1169460E (pt) 2006-07-31
EE05591B1 (et) 2012-10-15
KR100682185B1 (ko) 2007-02-12
EP1169460A2 (de) 2002-01-09
IL145842A (en) 2008-06-05
WO2000061768A2 (en) 2000-10-19
CA2368994C (en) 2010-03-09
KR20020007365A (ko) 2002-01-26
WO2000061768A3 (en) 2001-02-08
NO329525B1 (no) 2010-11-01
DE60028022D1 (de) 2006-06-22
EE200100530A (et) 2002-12-16
CN1324140C (zh) 2007-07-04
IL129427A0 (en) 2000-02-17
ZA200108364B (en) 2002-10-11
EP1169460B1 (de) 2006-05-17
CA2368994A1 (en) 2000-10-19
DK1169460T3 (da) 2006-09-18
US7098002B1 (en) 2006-08-29

Similar Documents

Publication Publication Date Title
ATE326536T1 (de) Herstellung von biologisch aktiven molekülen
ATE313317T1 (de) Herstellung von therapeutischem mikroschaum
DE69812901T2 (de) Katalytische herstellung von pentafluorpropenen
ATE240913T1 (de) Herstellung von betonbeschleuniger
ATE260343T1 (de) Bernsteinsäure herstellung und reinigung
DE60038200D1 (de) ren Herstellung und Verwendung
DE60018429D1 (de) Herstellung von poly(trimethylenterephthalat)
DE60027851D1 (de) Kontinuierliche Herstellung von Hitze-vulkanisierbarer Silikon Zusammensetzung
DE60013021D1 (de) Herstellung von S,S und R,S Aminosäuren-Isosteren
DE60019960D1 (de) Herstellung von isobutencopolymere
ATE546425T1 (de) Herstellung von (r)-2-alkyl-3-phenylpropionsäuren
DE59915061D1 (de) Herstellung von strukturierten elektroden
DE69804513D1 (de) Herstellung von zeolith-l
DE60028816D1 (de) Herstellung von unipolaren Komponenten
DE69908614D1 (de) Herstellung von n-substituierten-hydroxycycloalkylamin-derivaten
DE69900514D1 (de) Herstellung von Polyalkylsilsesquioxan-Partikeln
DE60007111D1 (de) Herstellung von ausgewählten fluorolefinen
DE69809433D1 (de) Herstellung von avermectin-verbindungen
DE60016608D1 (de) Herstellung von sulfonylimin-verbindungen
ATE251106T1 (de) Herstellung von carvon
DE60107191D1 (de) Herstellung von 2-Hydrocarbyl-2-Adamantylacrylaten
DE59804303D1 (de) Herstellung von Polyenaldehyden
DE60009048D1 (de) Herstellung von norlabdanoxid
DE60010725D1 (de) Herstellung von arylcarbonsäureestern
DE69811864D1 (de) Herstellung von bandförmigen werkstücken

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1169460

Country of ref document: EP